Women in Pharma® (WIP) – ISPE Iberia Affiliate is a community that provides women in the pharmaceutical industry a forum for connecting and collaborating on technical and career advancement topics.
Our community is also open to men supporting women’s professional development and willing to be an active contributor to change through breaking gender-bias in society and management styles.
Follow WIP ISPE Iberia Affiliate on linkedIn and help us shape the women leaders of today and tomorrow – WE ARE COUNTING ON YOU!
Women are proactive, powerful, and talented.
Women are stronger together, so we must connect ideas and support each other to inspire future professionals, and help creating opportunities to the more unfavored ones.
Men are important allies. The journey to diverse leadership positions can only be accomplished with men’s implication. Our collective goal must be that of an ecosystem (work & home) where both men and women have the same opportunities to grow, so that the best reaches the top for the benefit of the company, the industry and the patients.
To make WIP ISPE Iberia Affiliate the home for all women within the pharmaceutical industry, sharing the ambition to become better leaders both on the social and business fronts. We aim to help women reach their full potential, be successful, be equally treated and recognized, be brave, be interventive, and promote change.
We also invite and welcome every and all men sharing our vision.
WHAT WE DO
The community’s activities focus on:
Sharing inspiring stories from remarkable women who are role-models (interviews, publications, conversations, …)
Promoting events like workshops, webinars, and roundtables
Creating networking opportunities, through social and technical gatherings
Publishing content of quality in social media (original and third-party material/resources)
Follow WIP ISPE Iberia Affiliate on linkedIn to check all about our events.
WHO WE ARE
WIP Iberia is founded by a group of seasoned and dedicated Portuguese and Spanish Women professionally connected to the pharmaceutical industry: